Dr. Michael Luca Durando, MD, PhD

  • Silver City, NM
  • Hematologist and oncologist
NPI1750776910PAC ID6002171956
Medicare services, 2022
201
Part D claims, 2024
13
Publications
7
Hospital affiliations
2
Industry payments
$2,542
Practice address
1313 E 32nd St, Silver City, NM 88061
Practice phone
Call (575) 538-4100
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Gila Regional Medical Center

Hospital · Silver City, New Mexico

See all 6 affiliations

Find Dr. Durando's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael Luca Durando is a hematologist and oncologist in Silver City, New Mexico

Dr. Durando practices at Gila Regional Medical Center in Silver City, New Mexico, part of Grant County Solid Waste Department.

Dr. Durando's NPI, 1750776910, was assigned on April 3, 2015. Dr. Durando graduated from University of North Carolina at Chapel Hill School of Medicine in 2015. Dr. Durando holds Arizona license 61229.

NPI and contact details
Medicare PAC ID
6002171956
NPI enumeration date
April 3, 2015
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(575) 538-4100
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Michael Luca Durando practices at Gila Regional Medical Center in Silver City, New Mexico

Dr. Durando's primary practice is Gila Regional Medical Center, at 1313 E 32nd St, Silver City, NM 88061 in Grant County. The practice phone is (575) 538-4100.

Source: Dmand AI Affiliation Data

Dr. Michael Luca Durando is affiliated with 2 sites of care and 4 medical groups

Dr. Durando's primary practice is Gila Regional Medical Center in Silver City, New Mexico, part of Grant County Solid Waste Department. Dr. Durando is also affiliated with Eastern Idaho Regional Medical Center. The medical group on file is Gila Regional Medical Center. Dmand AI also links Dr. Durando to 3 more medical groups, each named with a free account. Dr. Durando's employer is on file too: a hospital.

See all 6 affiliations for Dr. Durando

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Michael Luca Durando's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Durando practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Gila Regional Medical CenterAvailable with a free account
+1 more site and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Durando practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Grant County Solid Waste Department and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael Luca Durando is one of 69 hematologists and oncologists in New Mexico

Hematology and oncology is Dr. Durando's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Durando's licenses on file in 3 states: Arizona, Pennsylvania and Utah.

Specialties and state licenses

  • Hematology and oncology, ArizonaPrimaryLicense 61229 · taxonomy 207RH0003X
  • Internal medicine, PennsylvaniaLicense MD467345 · taxonomy 207R00000X
  • Medical oncology, UtahLicense 12243243-1205 · taxonomy 207RX0202X

Hematologists and oncologists near Dr. Durando

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael Luca Durando billed Medicare for 201 services in 2022

CMS data shows 201 Medicare services from Dr. Durando across 6 procedure codes in 2022. Medicare paid $13,014 for them. Every service was in an office.

Medicare services, 2022201
Paid by Medicare$13,014
Procedure codes6

Dr. Durando's Medicare services by type, 2021 to 2022

  • 2021
  • 2022
Office and hospital visits
2021: 142022: 108671%
Lab and pathology
2021: 422022: 7783%
Tests and treatments
2021: 02022: 16

Dr. Durando compared with the New Mexico median for hematologists and oncologists, 2022

  • Dr. Durando
  • New Mexico median
Medicare services
201vs 48859% below
Part D claims
12vs 30196% below

Medians across 67 hematologists and oncologists in New Mexico with Dmand AI profiles that report each measure.

Dr. Durando's most billed Medicare procedure codes, 2022

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Durando

Need commercial claims for Dr. Durando?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Durando and other hematologists and oncologists in New Mexico.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Michael Luca Durando's patients have a median age of 74

Across all payers, Dmand AI patient panel data puts Dr. Durando's median patient age at 74, with 47% women.

Dr. Durando's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women47%
  • Men53%

Source: Dmand AI Patient Panel Data

Dr. Michael Luca Durando wrote 13 Medicare Part D claims in 2024

In 2024, Dr. Durando wrote 13 Medicare Part D claims. 92% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $7,822 in total drug cost. In 2021, CMS named 110 claims across 5 drugs.

Part D claims, 202413
Drugs named by CMS1
Total drug cost$7,822

Dr. Durando's Part D claims by kind of drug, 2024

  • Generic12 claims92%
  • Brand-name and other1 claims8%

Dr. Durando's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 1102022: 1289%

Drugs named by CMS: 1 in 2022, 5 in 2021.

See all prescribing by Dr. Durando

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Michael Luca Durando takes part in Medicare

Dr. Durando accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Durando by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael Luca Durando has 7 publications on record

Dmand AI links 7 papers to Dr. Durando, published from 2012 to 2017. 2013 was the busiest year, with 2. Dr. Durando's most frequent co-authors are Ajay Kumar Gopal, Daniel Oscar Persky, MD and Danny Gabriel Robles, MD.

Papers7
Years published2012 to 2017

Dr. Durando's papers by year, 2012 to 2017

Dr. Durando's most frequent co-authors

Recent publications by Dr. Durando

See all 7 publications and co-authors

See who Dr. Durando researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Durando works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael Luca Durando received $2,542 in industry payments from 2017 to 2025

CMS Open Payments shows 20 general payments to Dr. Durando from 17 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 79% of the total. Janssen Research & Development, LLC paid the most, $1,050.

General payments to Dr. Durando by program year, 2017 to 2025

General payments to Dr. Durando by kind, 2017 to 2025

$2.5Kin total
  • Consulting fees$2,01079%
  • Food and beverage$53221%

Companies that paid Dr. Durando the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Durando

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael Luca Durando graduated from University of North Carolina at Chapel Hill School of Medicine

Dr. Durando graduated from University of North Carolina at Chapel Hill School of Medicine in 2015.

  1. Medical schoolUniversity of North Carolina at Chapel Hill School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Michael Luca Durando's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael Luca Durando

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael Luca Durando's NPI number?

Dr. Michael Luca Durando's NPI number is 1750776910. It was assigned on April 3, 2015, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael Luca Durando?

Dr. Michael Luca Durando is a hematologist and oncologist in Silver City, New Mexico. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Michael Luca Durando practice?

Dr. Durando practices at 1313 E 32nd St, Silver City, NM 88061. Dr. Durando's primary practice is Gila Regional Medical Center in Silver City, New Mexico, part of Grant County Solid Waste Department. Dmand AI also links Dr. Durando to 3 medical groups.

What is Dr. Michael Luca Durando's office phone number?

The practice phone on file for Dr. Durando is (575) 538-4100.

What is Dr. Michael Luca Durando's medical license number?

Dr. Durando holds Arizona license 61229, one of the licenses on file in 3 states.

Which states has Dr. Michael Luca Durando been licensed in?

Dmand AI has state licenses on file for Dr. Durando in Arizona, Pennsylvania and Utah.

Which hospitals is Dr. Michael Luca Durando affiliated with?

Dr. Durando practices at Gila Regional Medical Center in Silver City, New Mexico. Dr. Durando is also affiliated with Eastern Idaho Regional Medical Center.

What medical group is Dr. Michael Luca Durando part of?

Dr. Durando is linked to Gila Regional Medical Center. Dmand AI links Dr. Durando to 3 more medical groups.

Does Dr. Michael Luca Durando accept Medicare?

Yes. CMS data shows Dr. Durando billed Medicare for 201 services in 2022, and Dr. Durando accepts Medicare assignment.

What services does Dr. Michael Luca Durando bill to Medicare?

In 2022, Dr. Durando's most billed Medicare services were office visit, established patient (99214), lab and pathology test (85025) and lab and pathology test (80053).

Show 6 more questionsShow fewer questions

Where did Dr. Michael Luca Durando go to medical school?

Dr. Durando graduated from University of North Carolina at Chapel Hill School of Medicine in 2015.

What drugs does Dr. Michael Luca Durando prescribe most?

In 2022 Medicare Part D data, Dr. Durando's most prescribed drugs by claims were Eliquis.

Has Dr. Michael Luca Durando received payments from drug or device companies?

CMS Open Payments shows $2,542 in general payments to Dr. Durando from 17 companies from 2017 to 2025. The largest total came from Janssen Research & Development, LLC.

How long has Dr. Michael Luca Durando been practicing?

Dr. Durando graduated from medical school in 2015, 11 years ago.

Does Dr. Michael Luca Durando do research?

Dmand AI links 7 publications to Dr. Durando, published from 2012 to 2017.

Who does Dr. Michael Luca Durando publish with?

Dr. Durando's most frequent co-authors are Ajay Kumar Gopal (1 shared paper), Daniel Oscar Persky, MD (1 shared paper) and Danny Gabriel Robles, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in New Mexico by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)